Omniab logo

Omniab Share Price Today

(NASDAQ: OABI)

Omniab share price is $1.85 & ₹157.60 as on 30 Apr 2025, 2.30 'hrs' IST

$1.85

0.05

(2.78%)

Market is closed - opens 7 PM, 30 Apr 2025

View live Omniab share price in Dollar and Rupees. Guide to invest in Omniab stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Omniab, along with analyst recommendations, forecasts, and comprehensive financials.

Omniab share price movements

  • Today's Low: $1.80
    Today's High: $1.87

    Day's Volatility :4.01%

  • 52 Weeks Low: $1.70
    52 Weeks High: $4.96

    52 Weeks Volatility :65.73%

Omniab (OABI) Returns

PeriodOmniab IncIndex (Russel 2000)
3 Months
-43.38%
0.0%
6 Months
-55.01%
0.0%
1 Year
-59.57%
0.0%
3 Years
-25.52%
-5.1%

Omniab (OABI) Key Statistics

in dollars & INR

Previous Close
$1.8
Open
$1.78
Today's High
$1.87
Today's Low
$1.795
Market Capitalization
$222.3M
Today's Volume
$1.1M
52 Week High
$4.96
52 Week Low
$1.7
Revenue TTM
$26.4M
EBITDA
$-53.3M
Earnings Per Share (EPS)
$-0.61
Profit Margin
-235.05%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-20.6%

How to invest in Omniab Stock (OABI) from India?

It is very easy for Indian residents to invest directly in Omniab from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Omniab stock in both Indian Rupees (INR) and US Dollars (USD). Search for Omniab or OABI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Omniab or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Omniab shares which would translate to 0.460 fractional shares of Omniab as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Omniab, in just a few clicks!

Returns in Omniab (OABI) for Indian investors in Rupees

The Omniab stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Omniab investment value today

Current value as on today

₹42,815

Returns

₹57,185

(-57.19%)

Returns from Omniab Stock

₹59,251 (-59.25%)

Dollar Returns

₹2,066 (+2.07%)

Indian investors sentiment towards Omniab (OABI)

-56%

Period: Mar 30, 2025 to Apr 29, 2025. Change in 30 Days versus previous period

Search interest for Omniab Stock from India on INDmoney has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Omniab

  • Avista Capital Holdings LP

    12.95%

  • HHG PLC

    6.52%

  • BlackRock Inc

    5.88%

  • Vanguard Group Inc

    4.14%

  • Macquarie Group Ltd

    3.52%

  • Dimensional Fund Advisors, Inc.

    2.48%

Analyst Recommendation on Omniab

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Omniab(by analysts ranked 0 to 5 stars)

Analyst Forecast on Omniab Stock (OABI)

What analysts predicted

Upside of 325.68%

Target:

$7.88

Current:

$1.85

Insights on Omniab Stock (Ticker Symbol: OABI)

  • Price Movement

    In the last 1 month, OABI stock has moved down by -25.8%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 4.17M → 10.80M (in $), with an average increase of 61.4% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -16.37M → -13.06M (in $), with an average increase of 25.3% per quarter
  • OABI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 73.0% return, outperforming this stock by 133.5%
  • Price to Sales

    ForOABI every $1 of sales, investors are willing to pay $7.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.6 for every $1 of sales.

Omniab Technicals Summary

Sell

Neutral

Buy

Omniab is currently in a neutral trading position according to technical analysis indicators.

Omniab (OABI) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Omniab Inc logo
-25.21%
-55.01%
-59.57%
-25.52%
-25.52%
Regeneron Pharmaceuticals, Inc. logo
-3.5%
-33.68%
-31.29%
-6.14%
16.46%
Beone Medicines Ltd logo
-8.24%
21.23%
62.23%
49.96%
78.11%
Vertex Pharmaceuticals Incorporated logo
2.53%
4.63%
26.54%
89.75%
95.01%
Alnylam Pharmaceuticals, Inc. logo
-5.61%
-9.46%
77.05%
83.29%
97.62%

About Omniab

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems of its proprietary and engineered transgenic animals to create optimized antibody candidates for human therapeutics. The company's animal-based technologies include OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences; OmniFlic, a bispecific rat and OmniClic, a bispecific chicken are designed for discovery of bispecific antibody applications; OmniTaur, which provides cow-inspired antibodies with unique structural characteristics for challenging targets; OmnidAb, an in vivo platform for the discovery of single-domain antibodies based upon a human VH scaffold; and OmniDeep, a suite of in silico, an artificial intelligence (AI) and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. The company has an agreement with mAbsolve Ltd. for its Fc-silencing platform technology to incorporate the STR technology into antibodies that have been generated using OmniAb's antibody discovery platform. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.
Organization
Omniab
Employees
114
CEO
Mr. Matthew W. Foehr
Industry
Healthcare

Management People of Omniab

NameTitle
Mr. Matthew W. Foehr
President, CEO & Director
Mr. Kurt A. Gustafson
Executive VP of Finance & CFO
Mr. Charles S. Berkman J.D.
Chief Legal Officer & Secretary
Ms. Cia McCaffrey
Vice President of People & Talent
Dr. Bill Harriman Ph.D.
Senior Vice President of Antibody Discovery
Ms. Marie-Cecile van de Lavoir D.V.M., Ph.D.
Senior Vice President of Technical Operations & Genetics
Dr. Christel Iffland Ph.D.
Senior Vice President of Antibody Technologies
Dr. Yasmina Noubia Abdiche Ph.D.
Senior Vice President of Exploratory Research
Ms. Donna Ventura CPA
Senior VP & Corporate Controller

Important FAQs about investing in OABI Stock from India :

What is Omniab share price today?

Omniab share price today stands at $1.85, Open: $1.78 ; Previous Close: $1.80 ; High: $1.87 ; Low: $1.80 ; 52 Week High: $4.96 ; 52 Week Low: $1.70.

The stock opens at $1.78, after a previous close of $1.80. The stock reached a daily high of $1.87 and a low of $1.80, with a 52-week high of $4.96 and a 52-week low of $1.70.

Can Indians buy Omniab shares?

Yes, Indians can invest in the Omniab (OABI) from India.

With INDmoney, you can buy Omniab at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Omniab at zero transaction cost.

How can I buy Omniab shares from India?

It is very easy to buy Omniab from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Omniab (OABI) be purchased?

Yes, you can buy fractional shares of Omniab with INDmoney app.

What are the documents required to start investing in Omniab stocks?

To start investing in Omniab, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Omniab Stock (OABI)?

Today’s highest price of Omniab (OABI) is $1.87.

Today’s lowest price of Omniab (OABI) is $1.80.

What is today's market capitalisation of Omniab?

Today's market capitalisation of Omniab OABI is 222.3M

What is the 52 Week High and Low Range of Omniab Stock (OABI)?

  • 52 Week High

    $4.96

  • 52 Week Low

    $1.70

What are the historical returns of Omniab (OABI)?

  • 1 Month Returns

    -25.21%

  • 3 Months Returns

    -55.01%

  • 1 Year Returns

    -59.57%

  • 5 Years Returns

    -25.52%

Who is the Chief Executive Officer (CEO) of Omniab ?

Mr. Matthew W. Foehr is the current Chief Executive Officer (CEO) of Omniab.